Multiple roles of metalloproteinases in neurological disorders

Progress in Molecular Biology and Translational Science

Volumn 99, Issue C, 2011, Pages 241-263

  Yang, Yi ^a   Hill, Jeff W ^a   Rosenberg, Gary A ^a  

^a UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

Author keywords

Basal lamina; Bloodbrain barrier; Brain edema; DNA repair enzymes; MMPs; Neuroinflammation; Neurological disorders; Tight junction proteins; TIMPs

Indexed keywords

EID: 78751639232     PISSN: 18771173     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-385504-6.00006-3     Document Type: Chapter

References (91)

1. L.A. Cunningham, M. Wetzel, and G.A. Rosenberg Multiple roles for MMPs and TIMPs in cerebral ischemia Glia 50 2005 329 339
2. V.W. Yong Metalloproteinases: mediators of pathology and regeneration in the CNS Nat Rev Neurosci 6 2005 931 944
3. L.K. Jian, and G.A. Rosenberg Matrix metalloproteinases and free radicals in cerebral ischemia Free Radic Biol Med 39 2005 71 80
4. E.H. Lo, T. Dalkara, and M.A. Moskowitz Mechanisms, challenges and opportunities in stroke Nat Rev Neurosci 4 2003 399 415
5. A. Page-McCaw, A.J. Ewald, and Z. Werb Matrix metalloproteinases and the regulation of tissue remodelling Nat Rev Mol Cell Biol 8 2007 221 233
6. T. Okamoto, T. Akuta, F. Tamura, A. van Der Vliet, and T. Akaike Molecular mechanism for activation and regulation of matrix metalloproteinases during bacterial infections and respiratory inflammation Biol Chem 385 2004 997 1006
7. Y.S. Kim, S.S. Kim, J.J. Cho, D.H. Choi, O. Hwang, and D.H. Shin Matrix metalloproteinase-3: a novel signaling proteinase from apoptotic neuronal cells that activates microglia J Neurosci 25 2005 3701 3711
8. Y. Yang, E. Candelario-Jalil, J.F. Thompson, E. Cuadrado, E.Y. Estrada, and A. Rosell Increased intranuclear matrix metalloproteinase activity in neurons interferes with oxidative DNA repair in focal cerebral ischemia J Neurochem 112 2010 134 149
9. R. Jin, G. Yang, and G. Li Molecular insights and therapeutic targets for blood-brain barrier disruption in ischemic stroke: critical role of matrix metalloproteinases and tissue-type plasminogen activator Neurobiol Dis 38 2010 376 385
10. J.M. Shipley, R.L. Wesselschmidt, D.K. Kobayashi, T.J. Ley, and S.D. Shapiro Metalloelastase is required for macrophage-mediated proteolysis and matrix invasion in mice Proc Natl Acad Sci USA 93 1996 3942 3946
11. D.H. Choi, E.M. Kim, H.J. Son, T.H. Joh, Y.S. Kim, and D. Kim A novel intracellular role of matrix metalloproteinase-3 during apoptosis of dopaminergic cells J Neurochem 106 2008 405 415
12. S. Zucker, D. Pei, J. Cao, and C. Lopez-Otin Membrane type-matrix metalloproteinases (MT-MMP) Curr Top Dev Biol 54 2003 1 74
13. S. McMahon, F. Grondin, P.P. McDonald, D.E. Richard, and C.M. Dubois Hypoxia-enhanced expression of the proprotein convertase furin is mediated by hypoxia-inducible factor-1: impact on the bioactivation of proproteins J Biol Chem 280 2005 6561 6569
14. P.E. Gottschall, and S. Deb Regulation of matrix metalloproteinase expressions in astrocytes, microglia and neurons Neuroimmunomodulation 3 1996 69 75 (Review)
15. S. Mun-Bryce, and G.A. Rosenberg Gelatinase B modulates selective opening of the blood-brain barrier during inflammation Am J Physiol 274 1998 R1203 R1211
16. S. Mun-Bryce, A. Lukes, J. Wallace, M. Lukes-Marx, and G.A. Rosenberg Stromelysin-1 and gelatinase A are upregulated before TNF-alpha in LPS-stimulated neuroinflammation Brain Res 933 2002 42 49
17. A. Rosell, C. Foerch, Y. Murata, and E.H. Lo Mechanisms and markers for hemorrhagic transformation after stroke Acta Neurochir Suppl 105 2008 173 178
18. G. Doronzo, I. Russo, L. Mattiello, M. Trovati, and G. Anfossi C-reactive protein increases matrix metalloproteinase-2 expression and activity in cultured human vascular smooth muscle cells J Lab Clin Med 146 2005 287 298
19. E. Hahn-Dantona, N. Ramos-DeSimone, J. Sipley, H. Nagase, D.L. French, and J.P. Quigley Activation of proMMP-9 by a plasmin/MMP-3 cascade in a tumor cell model. Regulation by tissue inhibitors of metalloproteinases Ann N Y Acad Sci 878 1999 372 387
20. G.A. Rosenberg, E.Y. Estrada, J.E. Dencoff, and W.G. Stetler-Stevenson Tumor necrosis factor-alpha-induced gelatinase B causes delayed opening of the blood-brain barrier: an expanded therapeutic window Brain Res 703 1995 151 155
21. K.J. Gurney, E.Y. Estrada, and G.A. Rosenberg Blood-brain barrier disruption by stromelysin-1 facilitates neutrophil infiltration in neuroinflammation Neurobiol Dis 23 2006 87 96
22. E. Candelario-Jalil, S. Taheri, Y. Yang, R. Sood, M. Grossetete, and E.Y. Estrada Cyclooxygenase inhibition limits blood-brain barrier disruption following intracerebral injection of tumor necrosis factor-alpha in the rat J Pharmacol Exp Ther 323 2007 488 498
23. R.M. Adibhatla, and J.F. Hatcher Tissue plasminogen activator (tPA) and matrix metalloproteinases in the pathogenesis of stroke: therapeutic strategies CNS Neurol Disord Drug Targets 7 2008 243 253
24. G.A. Rosenberg, J.E. Dencoff, N. Correa Jr., M. Reiners, and C.C. Ford Effect of steroids on CSF matrix metalloproteinases in multiple sclerosis: relation to blood-brain barrier injury Neurology 46 1996 1626 1632
25. L.J. Noble, F. Donovan, T. Igarashi, S. Goussev, and Z. Werb Matrix metalloproteinases limit functional recovery after spinal cord injury by modulation of early vascular events J Neurosci 22 2002 7526 7535
26. J.E. Wells, R.J. Hurlbert, M.G. Fehlings, and V.W. Yong Neuroprotection by minocycline facilitates significant recovery from spinal cord injury in mice Brain 126 2003 1628 1637
27. C.M. Overall, and C. Lopez-Otin Strategies for MMP inhibition in cancer: innovations for the post-trial era Nat Rev Cancer 2 2002 657 672
28. A.Y. Strongin, I. Collier, G. Bannikov, B.L. Marmer, G.A. Grant, and G.I. Goldberg Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease J Biol Chem 270 1995 5331 5338
29. M.A. Alfonso-Jaume, M.R. Bergman, R. Mahimkar, S. Cheng, Z.Q. Jin, and J.S. Karliner Cardiac ischemia-reperfusion injury induces matrix metalloproteinase-2 expression through the AP-1 components FosB and JunB Am J Physiol 291 2006 H1838 H1846
30. H. Nagase Activation mechanisms of matrix metalloproteinases Biol Chem 378 1997 151 160 (Review)
31. Z. Gu, M. Kaul, B. Yan, S.J. Kridel, J. Cui, and A. Strongin S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death Science 297 2002 1186 1190
32. M.A. Ali, and R. Schulz Activation of MMP-2 as a key event in oxidative stress injury to the heart Front Biosci 14 2009 699 716
33. X. Fu, S.Y. Kassim, W.C. Parks, and J.W. Heinecke Hypochlorous acid oxygenates the cysteine switch domain of pro-matrilysin (MMP-7). A mechanism for matrix metalloproteinase activation and atherosclerotic plaque rupture by myeloperoxidase J Biol Chem 276 2001 41279 41287
34. P. Mukhopadhyay, M. Rajesh, S. Batkai, Y. Kashiwaya, G. Hasko, and L. Liaudet Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro Am J Physiol 296 2009 H1466 H1483
35. Y. Wakisaka, Y. Chu, J.D. Miller, G.A. Rosenberg, and D.D. Heistad Spontaneous intracerebral hemorrhage during acute and chronic hypertension in mice J Cereb Blood Flow Metab 30 2010 56 69
36. K. Brew, and H. Nagase The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity Biochim Biophys Acta 1803 2010 55 71
37. A.H. Baker, D.R. Edwards, and G. Murphy Metalloproteinase inhibitors: biological actions and therapeutic opportunities J Cell Sci 115 2002 3719 3727
38. K.J. Leco, R. Khokha, N. Pavloff, S.P. Hawkes, and D.R. Edwards Tissue inhibitor of metalloproteinases-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues J Biol Chem 269 1994 9352 9360
39. J.A. Wallace, S. Alexander, E.Y. Estrada, C. Hines, L.A. Cunningham, and G.A. Rosenberg Tissue inhibitor of metalloproteinase-3 is associated with neuronal death in reperfusion injury J Cereb Blood Flow Metab 22 2002 1303 1310
40. M. Wetzel, L. Li, K.M. Harms, T. Roitbak, P.B. Ventura, and G.A. Rosenberg Tissue inhibitor of metalloproteinases-3 facilitates Fas-mediated neuronal cell death following mild ischemia Cell Death Differ 15 2008 143 151
41. D.M. Jaworski Differential regulation of tissue inhibitor of metalloproteinase mRNA expression in response to intracranial injury Glia 30 2000 199 208
42. D.M. Jaworski, and N. Fager Regulation of tissue inhibitor of metalloproteinase-3 (Timp-3) mRNA expression during rat CNS development J Neurosci Res 61 2000 396 408
43. W. Liu, T. Furuichi, M. Miyake, G.A. Rosenberg, and K.J. Liu Differential expression of tissue inhibitor of metalloproteinases-3 in cultured astrocytes and neurons regulates the activation of matrix metalloproteinase-2 J Neurosci Res 85 2007 829 836
44. U. Dirnagl, C. Iadecola, and M.A. Moskowitz Pathobiology of ischaemic stroke: an integrated view Trends Neurosci 22 1999 391 397
45. J.H. Heo, J. Lucero, T. Abumiya, J.A. Koziol, B.R. Copeland, and G.J. del Zoppo Matrix metalloproteinases increase very early during experimental focal cerebral ischemia J Cereb Blood Flow Metab 19 1999 624 633
46. G.A. Rosenberg, E.Y. Estrada, and J.E. Dencoff Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain Stroke 29 1998 2189 2195
47. Y. Yang, E.Y. Estrada, J.F. Thompson, W. Liu, and G.A. Rosenberg Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat J Cereb Blood Flow Metab 27 2007 697 709
48. S.R. Lee, H.Y. Kim, J. Rogowska, B.Q. Zhao, P. Bhide, and J.M. Parent Involvement of matrix metalloproteinase in neuroblast cell migration from the subventricular zone after stroke J Neurosci 26 2006 3491 3495
49. B.Q. Zhao, S. Wang, H.Y. Kim, H. Storrie, B.R. Rosen, and D.J. Mooney Role of matrix metalloproteinases in delayed cortical responses after stroke Nat Med 12 2006 441 445
50. L. Wang, Z.G. Zhang, R.L. Zhang, S.R. Gregg, A. Hozeska-Solgot, and Y. LeTourneau Matrix metalloproteinase 2 (MMP2) and MMP9 secreted by erythropoietin-activated endothelial cells promote neural progenitor cell migration J Neurosci 26 2006 5996 6003
51. Z. Gu, J. Cui, S. Brown, R. Fridman, S. Mobashery, and A.Y. Strongin A highly specific inhibitor of matrix metalloproteinase-9 rescues laminin from proteolysis and neurons from apoptosis in transient focal cerebral ischemia J Neurosci 25 2005 6401 6408
52. L.M. Coussens, B. Fingleton, and L.M. Matrisian Matrix metalloproteinase inhibitors and cancer: trials and tribulations Science 295 2002 2387 2392
53. J. Hu, P.E. Van den Steen, Q.X. Sang, and G. Opdenakker Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases Nat Rev Drug Discov 6 2007 480 498
54. B.T. Hawkins, and T.P. Davis The blood-brain barrier/neurovascular unit in health and disease Pharmacol Rev 57 2005 173 185
55. M. Furuse, K. Fujita, T. Hiiragi, K. Fujimoto, and S. Tsukita Claudin-1 and -2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin J Cell Biol 141 1998 1539 1550
56. D. Amantea, M.T. Corasaniti, N.B. Mercuri, G. Bernardi, and G. Bagetta Brain regional and cellular localization of gelatinase activity in rat that have undergone transient middle cerebral artery occlusion Neuroscience 152 2008 8 17
57. E. Cuadrado, A. Rosell, M. Borrell-Pages, L. Garcia-Bonilla, M. Hernandez-Guillamon, and A. Ortega-Aznar Matrix metalloproteinase-13 is activated and is found in the nucleus of neural cells after cerebral ischemia J Cereb Blood Flow Metab 29 2009 398 410
58. A.E. Vidal, S. Boiteux, I.D. Hickson, and J.P. Radicella XRCC1 coordinates the initial and late stages of DNA abasic site repair through protein-protein interactions EMBO J 20 2001 6530 6539
59. Y. Morita-Fujimura, M. Fujimura, Y. Gasche, J.C. Copin, and P.H. Chan Overexpression of copper and zinc superoxide dismutase in transgenic mice prevents the induction and activation of matrix metalloproteinases after cold injury-induced brain trauma J Cereb Blood Flow Metab 20 2000 130 138
60. K. Gijbels, S. Masure, H. Carton, and G. Opdenakker Gelatinase in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological disorders J Neuroimmunol 41 1992 29 34
61. S. Chandler, J. Cossins, J. Lury, and G. Wells Macrophage metalloelastase degrades matrix and myelin proteins and processes a tumour necrosis factor-alpha fusion protein Biochem Biophys Res Commun 228 1996 421 429
62. G.M. Liuzzi, M. Trojano, M. Fanelli, C. Avolio, A. Fasano, and P. Livrea Intrathecal synthesis of matrix metalloproteinase-9 in patients with multiple sclerosis: implication for pathogenesis Mult Scler 8 2002 222 228
63. A.K. Hewson, T. Smith, J.P. Leonard, and M.L. Cuzner Suppression of experimental allergic encephalomyelitis in the Lewis rat by the matrix metalloproteinase inhibitor Ro31-9790 Inflamm Res 44 1995 345 349
64. L.M. Metz, Y. Zhang, M. Yeung, D.G. Patry, R.B. Bell, and C.A. Stoian Minocycline reduces gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis Ann Neurol 55 2004 756
65. V.W. Yong, F. Giuliani, M. Xue, A. Bar-Or, and L.M. Metz Experimental models of neuroprotection relevant to multiple sclerosis Neurology 68 2007 S32 S37 discussion S43S54
66. D. Leppert, R.L. Lindberg, L. Kappos, and S.L. Leib Matrix metalloproteinases: multifunctional effectors of inflammation in multiple sclerosis and bacterial meningitis Brain Res Brain Res Rev 36 2001 249 257
67. S.L. Leib, J.M. Clements, R.L. Lindberg, C. Heimgartner, J.M. Loeffler, and L.A. Pfister Inhibition of matrix metalloproteinases and tumour necrosis factor alpha converting enzyme as adjuvant therapy in pneumococcal meningitis Brain 124 2001 1734 1742
68. H. Echchannaoui, S.L. Leib, U. Neumann, and R.M. Landmann Adjuvant TACE inhibitor treatment improves the outcome of TLR2-/- mice with experimental pneumococcal meningitis BMC Infect Dis 7 2007 25
69. G.A. Rosenberg, M. Navratil, F. Barone, and G. Feuerstein Proteolytic cascade enzymes increase in focal cerebral ischemia in rat J Cereb Blood Flow Metab 16 1996 360 366
70. Y. Gasche, M. Fujimura, Y. Morita-Fujimura, J.C. Copin, M. Kawase, and J. Massengale Early appearance of activated matrix metalloproteinase-9 after focal cerebral ischemia in mice: a possible role in blood-brain barrier dysfunction J Cereb Blood Flow Metab 19 1999 1020 1028
71. X. Wang, J. Jung, M. Asahi, W. Chwang, L. Russo, and M.A. Moskowitz Effects of matrix metalloproteinase-9 gene knock-out on morphological and motor outcomes after traumatic brain injury J Neurosci 20 2000 7037 7042
72. D.I. Chang, N. Hosomi, J. Lucero, J.H. Heo, T. Abumiya, and A.P. Mazar Activation systems for latent matrix metalloproteinase-2 are upregulated immediately after focal cerebral ischemia J Cereb Blood Flow Metab 23 2003 1408 1419
73. Anonymous Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group N Engl J Med 333 1995 1581 1587 (see comments)
74. C.R. Hornig, T. Bauer, C. Simon, S. Trittmacher, and W. Dorndorf Hemorrhagic transformation in cardioembolic cerebral infarction Stroke 24 1993 465 468
75. A. Rosell, A. Ortega-Aznar, J. varez-Sabin, I. Fernandez-Cadenas, M. Ribo, and C.A. Molina Increased brain expression of matrix metalloproteinase-9 after ischemic and hemorrhagic human stroke Stroke 37 2006 1399 1406
76. P.A. Lapchak, D.F. Chapman, and J.A. Zivin Metalloproteinase inhibition reduces thrombolytic (Tissue plasminogen Activator)-induced hemorrhage after thromboembolic stroke [In Process Citation) Stroke 31 2000 3034 3040
77. T. Pfefferkorn, and G.A. Rosenberg Closure of the blood-brain barrier by matrix metalloproteinase inhibition reduces rtPA-mediated mortality in cerebral ischemia with delayed reperfusion Stroke 34 2003 2025 2030
78. T. Sumii, and E.H. Lo Involvement of matrix metalloproteinase in thrombolysis-associated hemorrhagic transformation after embolic focal ischemia in rats Stroke 33 2002 831 836
79. J.V. Bowler Modern concept of vascular cognitive impairment Br Med Bull 83 2007 291 305
80. L.R. Caplan Binswanger's diseaserevisited Neurology 45 1995 626 633 (Review)
81. H. Wakita, H. Tomimoto, I. Akiguchi, and J. Kimura Glial activation and white matter changes in the rat brain induced by chronic cerebral hypoperfusion: an immunohistochemical study Acta Neuropathol (Berl) 87 1994 484 492
82. K. Nakaji, M. Ihara, C. Takahashi, S. Itohara, M. Noda, and R. Takahashi Matrix metalloproteinase-2 plays a critical role in the pathogenesis of white matter lesions after chronic cerebral hypoperfusion in rodents Stroke 37 2006 2816 2823
83. E. Farkas, P.G. Luiten, and F. Bari Permanent, bilateral common carotid artery occlusion in the rat: a model for chronic cerebral hypoperfusion-related neurodegenerative diseases Brain Res Brain Res Rev 54 2007 162 180
84. M. Ihara, H. Tomimoto, M. Kinoshita, J. Oh, M. Noda, and H. Wakita Chronic cerebral hypoperfusion induces MMP-2 but not MMP-9 expression in the microglia and vascular endothelium of white matter J Cereb Blood Flow Metab 21 2001 828 834
85. R. Sood, Y. Yang, S. Taheri, E. Candelario-Jalil, E.Y. Estrada, and E.J. Walker Increased apparent diffusion coefficients on MRI linked with matrix metalloproteinases and edema in white matter after bilateral carotid artery occlusion in rats J Cereb Blood Flow Metab 29 2009 308 316
86. J.C. Adair, J. Charlie, J.E. Dencoff, J.A. Kaye, J.F. Quinn, and R.M. Camicioli Measurement of gelatinase B (MMP-9) in the cerebrospinal fluid of patients with vascular dementia and Alzheimer disease Stroke 35 2004 e159 e162
87. J.X. Lin, H. Tomimoto, I. Akiguchi, A. Matsuo, H. Wakita, and H. Shibasaki Vascular cell components of the medullary arteries in Binswanger's disease brains: a morphometric and immunoelectron microscopic study Stroke 31 2000 1838 1842
88. G.A. Rosenberg, N. Sullivan, and M.M. Esiri White matter damage is assoiciated with matrix metalloproteinases in vascular dementia Stroke 32 2001 1162 1168
89. S. Chandler, R. Coates, A. Gearing, J. Lury, G. Wells, and E. Bone Matrix metalloproteinases degrade myelin basic protein Neurosci Lett 201 1995 223 226
90. A.W. Chung, H.H. Yang, M.W. Radomski, and C. van Breemen Long-term doxycycline is more effective than atenolol to prevent thoracic aortic aneurysm in marfan syndrome through the inhibition of matrix metalloproteinase-2 and -9 Circ Res 102 2008 e73 e85
91. E. Candelario-Jalil, Y. Yang, and G.A. Rosenberg Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia Neuroscience 159 2009 983 994